Merck moves Alzheimer's drug into big trials after safety review
(Reuters) - Merck & Co said it will begin two late-stage trials of its experimental Alzheimer's drug, one of the industry's best hopes for slowing the...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/rE7-0yZjwnw/story01.htm
No comments:
Post a Comment